載入...
Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function
We have previously reported that the fractalkine (FKN)/CX3CR1 system represents a novel regulatory mechanism for insulin secretion and β cell function. Here, we demonstrate that chronic administration of a long-acting form of FKN, FKN-Fc, can exert durable effects to improve glucose tolerance with i...
Na minha lista:
| 發表在: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5873865/ https://ncbi.nlm.nih.gov/pubmed/29504946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI94330 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|